
Axofit-G 300 Tablet
Marketer
SSK Pharma
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg) + Alpha Lipoic Acid (100mg)
Overview Axofit-G 300 Tablet
Neuropain-300 tablets combine medications to manage neuropathic pain. This treatment soothes overstimulated or injured nerves via central nervous system action, reducing pain perception and promoting nerve repair. Neuropain-300 should be taken on an empty stomach, consistently at the same time daily for optimal therapeutic levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course, even if symptoms improve. Discontinuing this medication abruptly is unsafe without consulting your physician. Common, mild side effects like drowsiness and dizziness may occur; avoid activities requiring alertness until the medication's effects are known. Weight gain is possible; regular exercise and a healthy diet can help manage this. Report any unusual mood shifts, worsening depression, or suicidal ideation to your doctor immediately. Disclose all other medications you're using, as interactions may reduce efficacy or alter the drug's action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Axofit-G 300 Tablet
Nerve-related pain
Major Benefits of Axofit-G 300 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Axofit-G 300 Tablets should be administered on an empty stomach.
Common Side effects of Axofit-G 300 Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Axofit-G 300 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Axofit-G 300 Tablet on an empty stomach.
How Axofit-G 300 Tablet works:
Axofit-G 300 Tablet combines gabapentin, methylcobalamin, and alpha-lipoic acid to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by regulating calcium channels in nerve cells. Methylcobalamin, a B vitamin, supports myelin production, shielding nerve fibers and aiding nerve cell repair. Alpha-lipoic acid, a naturally occurring antioxidant, protects brain and nerve tissue. This synergistic action provides relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Axofit-G 300 Tablet with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Axofit-G 300 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the risks and benefits prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Axofit-G 300 Tablets while breastfeeding is likely safe. Available human data indicate minimal risk to the infant. However, newborns should be observed for increased drowsiness and weight changes.
DrivingUNSAFE
Taking Axofit-G 300 Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Axofit-G 300 Tablets appear to pose minimal risk for individuals with kidney impairment. Preliminary findings indicate dose modification may not be necessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Axofit-G 300 Tablets appear to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Axofit-G 300 Tablet :
Should you forget a dose of Axofit-G 300 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Axofit-G 300 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
